Finance

Lists
GENPF:OTCMKTS
Genix Pharmaceuticals Corp
0,014 $
0,00%
(0,00) 1D
6 шіл., 09:30:05 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for GENPF...
Mkt. cap
1,22 млн
Avg. vol.
0,00
Volume
0,00
52-wk high
0,04 $
52-wk low
0,01 $
Beta
-1,00
Shares outstanding
61,22 млн
Mkt. cap
1,22 млн
Avg. vol.
0,00
Volume
0,00
52-wk high
0,04 $
52-wk low
0,01 $
Beta
-1,00
Shares outstanding
61,22 млн
News stories
From web sources and news partners
About Genix Pharmaceuticals Corp
CEO-
Employees-
Founded1993
HeadquartersВанкувер, Британдық Колумбия, Канада
SectorPersonal care products
Websitegenixpharm.com
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in CAD
2025 ж. шіл.
2025 ж. қаз.
2026 ж. қаң.
2026 ж. сәу.
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
32,45 мың
30,90 мың
21,28 мың
23,20 мың
Operating expense
32,73 мың
31,18 мың
21,28 мың
23,20 мың
Total operating expenses
32,73 мың
31,18 мың
21,28 мың
23,20 мың
Operating income
-32,73 мың
-31,18 мың
-21,28 мың
-23,20 мың
Other non operating income
-7,96 мың
-2,35 мың
-2,42 мың
-3,70 мың
EBT including unusual items
-83,50 мың
-92,32 мың
-51,64 мың
-78,42 мың
EBT excluding unusual items
-83,50 мың
-86,68 мың
-51,64 мың
-78,42 мың
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-83,50 мың
-92,32 мың
-51,64 мың
-78,42 мың
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
25,00
129,00
164,00
66,00
Interest expense
-42,01 мың
-48,53 мың
-40,56 мың
-49,89 мың
Net interest expenses
-41,99 мың
-48,40 мың
-40,40 мың
-49,82 мың
Depreciation and amortization charges
-
-
-
-
EBITDA
-32,45 мың
-30,90 мың
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google қолданбалары